Haleon (HLN) Research & Development (2021 - 2023)
Haleon (HLN) posted Research & Development of -$269.3 million for Q4 2023, down 221.24% on a QoQ basis from -$83.8 million in Q2 2023, and down 5.33% year-over-year from -$284.5 million in Q4 2022.
Haleon (HLN) Research & Development (2021 - 2023) Analysis & Trends
Haleon's Research & Development history runs 3 years deep, the most recent figure standing at -$269.3 million for Q4 2023.
- Quarterly Research & Development fell 5.33% year-over-year to -$269.3 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was -$700.6 million (changed N/A YoY) and the FY2025 annual result came in at $416.6 million, up 9.38% from the prior year.
- Research & Development was -$269.3 million for Q4 2023 at Haleon, down from -$83.8 million in the prior quarter.
- Across five years, Research & Development topped out at -$83.8 million in Q2 2023 and bottomed at -$269.3 million in Q4 2023.
- A 3-year average of -$185.8 million and a median of -$207.1 million in 2021 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development slipped 3.65% — and 2023, when it retreated 5.33%.
- Haleon's Research & Development stood at -$246.7 million in 2021, then decreased by 3.65% to -$255.7 million in 2022, then decreased by 5.33% to -$269.3 million in 2023.
- Business Quant data shows HLN's Research & Development at -$269.3 million in Q4 2023, -$83.8 million in Q2 2023, and -$91.7 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 696.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 180.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 7.37 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 138.20 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 248.60 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 296.20 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 97.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -269.33 Mn |
| Jun 30, 2023 | -83.84 Mn |
| May 3, 2023 | -91.71 Mn |
| Dec 31, 2022 | -255.70 Mn |
| Sep 20, 2022 | -167.46 Mn |
| Dec 31, 2021 | -246.69 Mn |